Roche Holding Ltd. (ROG) Rating Reiterated by J P Morgan Chase & Co

Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reaffirmed by equities research analysts at J P Morgan Chase & Co in a research note issued on Monday, October 9th.

A number of other equities analysts have also issued reports on ROG. Barclays PLC set a CHF 305 price target on shares of Roche Holding and gave the stock a “buy” rating in a research report on Tuesday, June 13th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the stock a “buy” rating in a research report on Thursday, June 15th. Jefferies Group LLC set a CHF 285 price target on shares of Roche Holding and gave the stock a “buy” rating in a research report on Friday, June 16th. BNP Paribas set a CHF 250 price target on shares of Roche Holding and gave the stock a “neutral” rating in a research report on Tuesday, June 20th. Finally, Deutsche Bank AG set a CHF 273 price target on shares of Roche Holding and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of CHF 265.40.

Shares of Roche Holding (ROG) opened at 245.50 on Monday. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00. The firm’s 50-day moving average is CHK 244.91 and its 200-day moving average is CHK 251.19. The stock has a market capitalization of CHK 209.48 billion and a PE ratio of 21.80.

TRADEMARK VIOLATION WARNING: “Roche Holding Ltd. (ROG) Rating Reiterated by J P Morgan Chase & Co” was originally posted by BBNS and is the property of of BBNS. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://baseballnewssource.com/markets/roche-holding-ltd-rog-given-buy-rating-at-j-p-morgan-chase-co-2/1700141.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.